Table 4.
Multivariate analysis for overall survival according to the objective response to neoadjuvant therapy
| Class | Number of observation | Hazard ratio (95% CI) | P |
|---|---|---|---|
| ypN | |||
| N0 | 45 | 1 | 0.0001 |
| N1, N2, N3 | 52 | 5.26 (2.27–12.2) | |
| ypT | |||
| T0 | 10 | 1 | 0.2271 |
| T1, T2, T3, T4 | 87 | 3.47 (0.461–026.0) | |
| Objective response | |||
| Progression | 9 | 2.49 (1.18–5.26) | 0.0163 |
| Response | 44 | 1 | |
| Stable | 44 | 4.20 (1.25–14.1) | |
| ASA | |||
| 1 | 20 | 1 | 0.2466 |
| 2–3 | 77 | 0.625 (0.282–1.38) |
ASA: American Society of Anesthesiologists; CI: Confidence interval.